Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Polycystic Ovary Syndrome Treatment Market Size Growth Rate by Type (2014-2025) 1.4.2 Oral Contraceptives 1.4.3 Insulin Sensitizing Agents 1.4.4 Anti-Depressants 1.4.5 Ornithine Decarboxylase Inhibitors 1.4.6 Aromatase Inhibitors 1.4.7 Diuretics 1.5 Market by Application 1.5.1 Global Polycystic Ovary Syndrome Treatment Market Share by Application (2019-2025) 1.5.2 Hospital Pharmacies 1.5.3 Drug Stores 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Polycystic Ovary Syndrome Treatment Market Size 2.2 Polycystic Ovary Syndrome Treatment Growth Trends by Regions 2.2.1 Polycystic Ovary Syndrome Treatment Market Size by Regions (2019-2025) 2.2.2 Polycystic Ovary Syndrome Treatment Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Polycystic Ovary Syndrome Treatment Market Size by by Players 3.1.1 Global Polycystic Ovary Syndrome Treatment Revenue by by Players (2014-2019) 3.1.2 Global Polycystic Ovary Syndrome Treatment Revenue Market Share by by Players (2014-2019) 3.1.3 Global Polycystic Ovary Syndrome Treatment Market Concentration Ratio (CR5 and HHI) 3.2 Polycystic Ovary Syndrome Treatment Key Players Head office and Area Served 3.3 Key Players Polycystic Ovary Syndrome Treatment Product/Solution/Service 3.4 Date of Enter into Polycystic Ovary Syndrome Treatment Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Polycystic Ovary Syndrome Treatment Market Size by Type (2014-2019) 4.2 Global Polycystic Ovary Syndrome Treatment Market Size by Application (2014-2019) 5 North America 5.1 North America Polycystic Ovary Syndrome Treatment Market Size (2014-2019) 5.2 Polycystic Ovary Syndrome Treatment Key Players in North America 5.3 North America Polycystic Ovary Syndrome Treatment Market Size by Type 5.4 North America Polycystic Ovary Syndrome Treatment Market Size by Application 6 Europe 6.1 Europe Polycystic Ovary Syndrome Treatment Market Size (2014-2019) 6.2 Polycystic Ovary Syndrome Treatment Key Players in Europe 6.3 Europe Polycystic Ovary Syndrome Treatment Market Size by Type 6.4 Europe Polycystic Ovary Syndrome Treatment Market Size by Application 7 China 7.1 China Polycystic Ovary Syndrome Treatment Market Size (2014-2019) 7.2 Polycystic Ovary Syndrome Treatment Key Players in China 7.3 China Polycystic Ovary Syndrome Treatment Market Size by Type 7.4 China Polycystic Ovary Syndrome Treatment Market Size by Application 8 Japan 8.1 Japan Polycystic Ovary Syndrome Treatment Market Size (2014-2019) 8.2 Polycystic Ovary Syndrome Treatment Key Players in Japan 8.3 Japan Polycystic Ovary Syndrome Treatment Market Size by Type 8.4 Japan Polycystic Ovary Syndrome Treatment Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Polycystic Ovary Syndrome Treatment Market Size (2014-2019) 9.2 Polycystic Ovary Syndrome Treatment Key Players in Southeast Asia 9.3 Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Type 9.4 Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Application 10 India 10.1 India Polycystic Ovary Syndrome Treatment Market Size (2014-2019) 10.2 Polycystic Ovary Syndrome Treatment Key Players in India 10.3 India Polycystic Ovary Syndrome Treatment Market Size by Type 10.4 India Polycystic Ovary Syndrome Treatment Market Size by Application 11 Central & South America 11.1 Central & South America Polycystic Ovary Syndrome Treatment Market Size (2014-2019) 11.2 Polycystic Ovary Syndrome Treatment Key Players in Central & South America 11.3 Central & South America Polycystic Ovary Syndrome Treatment Market Size by Type 11.4 Central & South America Polycystic Ovary Syndrome Treatment Market Size by Application 12 International Players Profiles 12.1 Sanofi 12.1.1 Sanofi Company Details 12.1.2 Company Description and Business Overview 12.1.3 Polycystic Ovary Syndrome Treatment Introduction 12.1.4 Sanofi Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)) 12.1.5 Sanofi Recent Development 12.2 Novartis AG 12.2.1 Novartis AG Company Details 12.2.2 Company Description and Business Overview 12.2.3 Polycystic Ovary Syndrome Treatment Introduction 12.2.4 Novartis AG Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019) 12.2.5 Novartis AG Recent Development 12.3 Teva Pharmaceutical Industries Limited  12.3.1 Teva Pharmaceutical Industries Limited  Company Details 12.3.2 Company Description and Business Overview 12.3.3 Polycystic Ovary Syndrome Treatment Introduction 12.3.4 Teva Pharmaceutical Industries Limited  Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019) 12.3.5 Teva Pharmaceutical Industries Limited  Recent Development 12.4 Addex Therapeutics Ltd.  12.4.1 Addex Therapeutics Ltd.  Company Details 12.4.2 Company Description and Business Overview 12.4.3 Polycystic Ovary Syndrome Treatment Introduction 12.4.4 Addex Therapeutics Ltd.  Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019) 12.4.5 Addex Therapeutics Ltd.  Recent Development 12.5 BIOCAD 12.5.1 BIOCAD Company Details 12.5.2 Company Description and Business Overview 12.5.3 Polycystic Ovary Syndrome Treatment Introduction 12.5.4 BIOCAD Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019) 12.5.5 BIOCAD Recent Development 12.6 Merck KGaA 12.6.1 Merck KGaA Company Details 12.6.2 Company Description and Business Overview 12.6.3 Polycystic Ovary Syndrome Treatment Introduction 12.6.4 Merck KGaA Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019) 12.6.5 Merck KGaA Recent Development 12.7 AstraZeneca plc. 12.7.1 AstraZeneca plc. Company Details 12.7.2 Company Description and Business Overview 12.7.3 Polycystic Ovary Syndrome Treatment Introduction 12.7.4 AstraZeneca plc. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019) 12.7.5 AstraZeneca plc. Recent Development 12.8 Bristol Myers Squibb Co.  12.8.1 Bristol Myers Squibb Co.  Company Details 12.8.2 Company Description and Business Overview 12.8.3 Polycystic Ovary Syndrome Treatment Introduction 12.8.4 Bristol Myers Squibb Co.  Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019) 12.8.5 Bristol Myers Squibb Co.  Recent Development 12.9 Ferring Pharmaceuticals, Inc. 12.9.1 Ferring Pharmaceuticals, Inc. Company Details 12.9.2 Company Description and Business Overview 12.9.3 Polycystic Ovary Syndrome Treatment Introduction 12.9.4 Ferring Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019) 12.9.5 Ferring Pharmaceuticals, Inc. Recent Development 12.10 Crinetics Pharmaceuticals, Inc. 12.10.1 Crinetics Pharmaceuticals, Inc. Company Details 12.10.2 Company Description and Business Overview 12.10.3 Polycystic Ovary Syndrome Treatment Introduction 12.10.4 Crinetics Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019) 12.10.5 Crinetics Pharmaceuticals, Inc. Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Polycystic Ovary Syndrome Treatment Key Market Segments Table Key Players Polycystic Ovary Syndrome Treatment Covered Table Global Polycystic Ovary Syndrome Treatment Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Oral Contraceptives Figures Table Key Players of Oral Contraceptives Figuer Insulin Sensitizing Agents Figures Table Key Players of Insulin Sensitizing Agents Figuer Anti-Depressants Figures Table Key Players of Anti-Depressants Figuer Ornithine Decarboxylase Inhibitors Figures Table Key Players of Ornithine Decarboxylase Inhibitors Figuer Aromatase Inhibitors Figures Table Key Players of Aromatase Inhibitors Figuer Diuretics Figures Table Key Players of Diuretics Table Global Polycystic Ovary Syndrome Treatment Market Size Growth by Application 2019-2025 (Million US$) Figure Global Polycystic Ovary Syndrome Treatment Market Share by Application in 2018 & 2025 Figure Hospital Pharmacies Case Studies Figure Drug Stores Case Studies Figure Polycystic Ovary Syndrome Treatment Report Years Considered Figure Global Polycystic Ovary Syndrome Treatment Market Size and Growth Rate 2014-2025 (Million US$) Table Global Polycystic Ovary Syndrome Treatment Market Size by Regions 2019-2025 (Million US$) Table Global Polycystic Ovary Syndrome Treatment Market Size by Regions 2019-2025 (Million US$) Table Global Polycystic Ovary Syndrome Treatment Market Share by Regions 2014-2019 Figure Global Polycystic Ovary Syndrome Treatment Market Share by Regions 2014-2019 Figure Global Polycystic Ovary Syndrome Treatment Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Polycystic Ovary Syndrome Treatment Revenue by by Players (2014-2019) (Million US$) Table Global Polycystic Ovary Syndrome Treatment Market Share by by Players (2014-2019) Figure Global Polycystic Ovary Syndrome Treatment Market Share by by Players in 2018 Table Global Polycystic Ovary Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Polycystic Ovary Syndrome Treatment Product/Solution/Service Table Date of Enter into Polycystic Ovary Syndrome Treatment Market Table Mergers & Acquisitions, Expansion Plans Table Global Polycystic Ovary Syndrome Treatment Market Size by Type (2014-2019) (Million US$) Table Global Polycystic Ovary Syndrome Treatment Market Size Share by Type (2014-2019) Figure Global Polycystic Ovary Syndrome Treatment Market Size Market Share by Type (2014-2019) Table Global Polycystic Ovary Syndrome Treatment Market Size by Application (2014-2019) (Million US$) Table Global Polycystic Ovary Syndrome Treatment Market Size Share by Application (2014-2019) Figure Global Polycystic Ovary Syndrome Treatment Market Size Market Share by Application (2014-2019) Figure Global Polycystic Ovary Syndrome Treatment Revenue Market Share by Application in 2018 Figure North America Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$) Table North America Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$) Table North America Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019) Table North America Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$) Table North America Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019 Table North America Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$) Table North America Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019 Figure Europe Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$) Table Europe Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$) Table Europe Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019) Table Europe Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$) Table Europe Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019 Table Europe Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$) Table Europe Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019 Figure China Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$) Table China Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$) Table China Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019) Table China Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$) Table China Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019 Table China Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$) Table China Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019 Figure Japan Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$) Table Japan Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$) Table Japan Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019) Table Japan Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$) Table Japan Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019 Table Japan Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$) Table Japan Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019 Figure Southeast Asia Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019) Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019 Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019 Figure India Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$) Table India Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$) Table India Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019) Table India Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$) Table India Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019 Table India Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$) Table India Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019 Figure Central & South America Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$) Table Central & South America Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$) Table Central & South America Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019) Table Central & South America Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$) Table Central & South America Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019 Table Central & South America Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$) Table Central & South America Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019 Table Sanofi Company Details Table Sanofi Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$) Figure Sanofi Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019) Table Sanofi Recent Development Table Novartis AG Company Details Table Novartis AG Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$) Figure Novartis AG Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019) Table Novartis AG Recent Development Table Teva Pharmaceutical Industries Limited  Company Details Table Teva Pharmaceutical Industries Limited  Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$) Figure Teva Pharmaceutical Industries Limited  Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019) Table Teva Pharmaceutical Industries Limited  Recent Development Table Addex Therapeutics Ltd.  Company Details Table Addex Therapeutics Ltd.  Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$) Figure Addex Therapeutics Ltd.  Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019) Table Addex Therapeutics Ltd.  Recent Development Table BIOCAD Company Details Table BIOCAD Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$) Figure BIOCAD Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019) Table BIOCAD Recent Development Table Merck KGaA Company Details Table Merck KGaA Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$) Figure Merck KGaA Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019) Table Merck KGaA Recent Development Table AstraZeneca plc. Company Details Table AstraZeneca plc. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$) Figure AstraZeneca plc. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019) Table AstraZeneca plc. Recent Development Table Bristol Myers Squibb Co.  Company Details Table Bristol Myers Squibb Co.  Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$) Figure Bristol Myers Squibb Co.  Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019) Table Bristol Myers Squibb Co.  Recent Development Table Ferring Pharmaceuticals, Inc. Company Details Table Ferring Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$) Figure Ferring Pharmaceuticals, Inc. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019) Table Ferring Pharmaceuticals, Inc. Recent Development Table Crinetics Pharmaceuticals, Inc. Company Details Table Crinetics Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$) Figure Crinetics Pharmaceuticals, Inc. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019) Table Crinetics Pharmaceuticals, Inc. Recent Development Table Global Polycystic Ovary Syndrome Treatment Market Size by Regions (Million US$) 2019-2025 Figure Global Polycystic Ovary Syndrome Treatment Market Size Share by Regions (2019-2025) Figure Global Polycystic Ovary Syndrome Treatment Market Size Share by Regions in 2025 Figure North America Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD) Figure Europe Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD) Figure China Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD) Figure Japan Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD) Figure India Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD) Table Global Polycystic Ovary Syndrome Treatment Market Size by Product (2019-2025) (Million US$) Figure Global Polycystic Ovary Syndrome Treatment Market Size by Product (2019-2025) Figure Global Polycystic Ovary Syndrome Treatment Market Size by Product in 2025 Table Global Polycystic Ovary Syndrome Treatment Market Size by Application (2019-2025) (Million US$) Figure Global Polycystic Ovary Syndrome Treatment Market Size by Application (2019-2025) Figure Global Polycystic Ovary Syndrome Treatment Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Sanofi Novartis AG Teva Pharmaceutical Industries Limited  Addex Therapeutics Ltd.  BIOCAD Merck KGaA AstraZeneca plc. Bristol Myers Squibb Co.  Ferring Pharmaceuticals, Inc. Crinetics Pharmaceuticals, Inc.